INMUNE BIO INC's ticker is and the CUSIP is 45782T905. A total of 3 filers reported holding INMUNE BIO INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3 | -70.0% | 500 | -58.3% | 0.00% | – |
Q2 2023 | $10 | -81.8% | 1,200 | -86.0% | 0.00% | – |
Q1 2023 | $55 | +400.0% | 8,600 | +377.8% | 0.00% | – |
Q4 2022 | $11 | -99.9% | 1,800 | -35.7% | 0.00% | – |
Q3 2022 | $17,000 | -52.8% | 2,800 | -31.7% | 0.00% | – |
Q2 2022 | $36,000 | +111.8% | 4,100 | +95.2% | 0.00% | – |
Q1 2022 | $17,000 | -59.5% | 2,100 | -50.0% | 0.00% | – |
Q4 2021 | $42,000 | -32.3% | 4,200 | +23.5% | 0.00% | – |
Q3 2021 | $62,000 | +5.1% | 3,400 | 0.0% | 0.00% | – |
Q2 2021 | $59,000 | – | 3,400 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
GROUP ONE TRADING, L.P. | 200 | $4,000 | 0.00% |
SIMPLEX TRADING, LLC | 3,400 | $59,000 | 0.00% |